Literature DB >> 22802281

Coagulation cascade proteinases in lung injury and fibrosis.

Rachel C Chambers1, Chris J Scotton.   

Abstract

The primary function of the coagulation cascade is to promote hemostasis and limit blood loss in response to tissue injury. In addition, there is now considerable evidence that coagulation plays pivotal roles in orchestrating inflammatory and tissue repair responses via both the generation of fibrin and activation of the family of proteinase-activated receptors (PARs). Consequently, uncontrolled coagulation and PAR signaling responses have been shown to contribute to excessive inflammatory and fibroproliferative responses in the context of a broad range of conditions, including acute lung injury and fibrotic lung disease. In terms of the cellular origin of excessive coagulation activity in the context of lung injury, coagulation zymogens are principally thought to be derived from the circulation and locally activated via the extrinsic tissue factor-dependent coagulation pathway within the intraalveolar compartment. More recently, we have provided compelling evidence that several key coagulation zymogens are locally synthesized by the hyperplastic alveolar epithelium in pulmonary fibrosis. In terms of signaling receptors activated in response to the coagulation cascade, current evidence suggests a major role for PAR1 in influencing endothelial-epithelial barrier disruption, inflammatory cell recruitment, and collagen deposition in response to lung injury, whereas PAR2 signaling has been implicated mainly in mediating lung inflammatory responses. This article reviews current understanding of coagulation pathways in acute and fibrotic lung injury and expands on the scientific rationale for strategies that specifically target intraalveolar coagulation or PAR signaling responses.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22802281     DOI: 10.1513/pats.201201-006AW

Source DB:  PubMed          Journal:  Proc Am Thorac Soc        ISSN: 1546-3222


  30 in total

1.  Reply: rationale for anticoagulant therapy of pulmonary fibrosis.

Authors:  Imre Noth; Mitchell A Olman
Journal:  Am J Respir Crit Care Med       Date:  2014-02-01       Impact factor: 21.405

2.  IL-13 Augments Compressive Stress-Induced Tissue Factor Expression in Human Airway Epithelial Cells.

Authors:  Jennifer A Mitchel; Silvio Antoniak; Joo-Hyeon Lee; Sae-Hoon Kim; Maureen McGill; David I Kasahara; Scott H Randell; Elliot Israel; Stephanie A Shore; Nigel Mackman; Jin-Ah Park
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

3.  A blood meal-induced Ixodes scapularis tick saliva serpin inhibits trypsin and thrombin, and interferes with platelet aggregation and blood clotting.

Authors:  Adriana M G Ibelli; Tae K Kim; Creston C Hill; Lauren A Lewis; Mariam Bakshi; Stephanie Miller; Lindsay Porter; Albert Mulenga
Journal:  Int J Parasitol       Date:  2014-02-28       Impact factor: 3.981

4.  Circulating Biomarkers From the Phase 1 Trial of Sirolimus and Autophagy Inhibition for Patients With Lymphangioleiomyomatosis.

Authors:  Anthony M Lamattina; Angelo Taveira-Dasilva; Hilary J Goldberg; Shefali Bagwe; Ye Cui; Ivan O Rosas; Joel Moss; Elizabeth P Henske; Souheil El-Chemaly
Journal:  Chest       Date:  2018-08-23       Impact factor: 9.410

5.  Hematopoietic protease nexin-1 protects against lung injury by preventing thrombin signaling in mice.

Authors:  Deborah François; Véronique Arocas; Laurence Venisse; Karen Aymonnier; Leila Idir; Raphael Martos; Salome Gazit; Ludovic Couty; Martine Jandrot-Perrus; Eric Camerer; Yacine Boulaftali; Marie-Christine Bouton
Journal:  Blood Adv       Date:  2018-09-25

6.  Dabigatran mitigates cisplatin-mediated nephrotoxicity through down regulation of thrombin pathway.

Authors:  Mohamed Gamal El-Din Ewees; Mohamed Sadek Abdel-Bakky; Asmaa Mostafa Ahmed Bayoumi; Ali Ahmed Abo-Saif; Waleed Mohammad Altowayan; Khalid Saad Alharbi; Basim Anwar Shehata Messiha
Journal:  J Adv Res       Date:  2021-01-05       Impact factor: 10.479

Review 7.  Characteristics and evaluation of acute exacerbations in chronic interstitial lung diseases.

Authors:  Corey D Kershaw; Kiran Batra; Jose R Torrealba; Lance S Terada
Journal:  Respir Med       Date:  2021-04-26       Impact factor: 4.582

8.  Regulation of neutrophilic inflammation by proteinase-activated receptor 1 during bacterial pulmonary infection.

Authors:  Ricardo J José; Andrew E Williams; Paul F Mercer; Michal G Sulikowski; Jeremy S Brown; Rachel C Chambers
Journal:  J Immunol       Date:  2015-05-06       Impact factor: 5.422

9.  Advocacy of targeting protease-activated receptors in severe coronavirus disease 2019.

Authors:  Saravanan Subramaniam; Wolfram Ruf; Markus Bosmann
Journal:  Br J Pharmacol       Date:  2021-07-07       Impact factor: 8.739

Review 10.  Proteases, Mucus, and Mucosal Immunity in Chronic Lung Disease.

Authors:  Michael C McKelvey; Ryan Brown; Sinéad Ryan; Marcus A Mall; Sinéad Weldon; Clifford C Taggart
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.